__NUXT_JSONP__("/drugs/Amatuximab", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"931402-35-6",chebiId:"",chemicalFormula:"C6394H9870N1694O2024S46",definition:"A chimeric IgG1 monoclonal antibody against human mesothelin with potential anti-tumor activity. Amatuximab specifically targets mesothelin, a cell surface glycoprotein involved in cell adhesion and overexpressed on many epithelial-derived cancer cells. Upon binding to the mesothelin antigen, amatuximab triggers an antibody dependent cellular cytotoxicity (ADCC)-mediated host immune response against mesothelin-expressing cells, resulting in cell lysis.",fdaUniiCode:"6HP0354G04",identifier:"C62483",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C20401"],synonyms:["AMATUXIMAB",a,"Anti-Mesothelin Monoclonal Antibody MORAb-009","Immunoglobulin G1, Anti-(mesothelin) (Human-Mouse Monoclonal MORAb-009 Heavy Chain), Disulfide with Human-Mouse Monoclonal MORAb-009 Kappa-Chain, Dimer","MORAb-009","anti-mesothelin monoclonal antibody MORAb-009"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAmatuximab",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Amatuximab","2021-10-30T13:42:05.873Z")));